Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 7101-7109

  Nakano, Isao ^a   Maertens, Geert ^b   Major, Marian E ^a,e   Vitvitski, Ludmila ^a   Dubuisson, Jean ^b   Fournillier, Anne ^a   De Martynoff, Guy ^c   Trepo, Christian ^a   Inchauspe, Genevieve ^a,d  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c INNOGENETICS   (Belgium)

^d Retrovirus Humains et Pathologies A   (France)

^e CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C VIRUS; HEPATITIS NON A NON B; HUMORAL IMMUNITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRION; VIRUS ENVELOPE;

EID: 0030817934     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.7101-7109.1997     Document Type: Article

References (54)

1. Bos, J. D., and M. L. Kapsenberg. 1993. The skin immune system: progress in cutaneous biology. Immunol. Today 14:75-78.
2. Botarelli, P., M. R. Brunetto, M. A. Minutello, P. Calvo, D. Unumaaz, A. J. Weiner, Q.-L. Choo, J. R. Shuster, G. Kuo, F. Bonino, M. Houghton, and S. Abrigiani. 1993. T-lymphocyte response to hepatitis C virus in clinical courses of infection. Gastroenterology 104:580-587.
3. Cahour, A. 1995. Les perspectives d'un vaccin contre 1'hépatite C: quelle stratégie adopter? Med. Sci. 11:81-91.
4. Choo, Q.-L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
5. Choo, Q.-L., G. Kuo, R. Ralston, A. Weiner, D. Chien, G. Van Nest, J. Han, K. Berger, K. Thudium, and C. Kuo. 1994. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA 91: 1294-1298.
6. Davis, H. L., L. M. Michel, and R. G. Whalen. 1993. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 3:1847-1851.
7. Delpeyroux, F., N. Chenciner, A. Lim, Y. Malpiece, B. Blondel, R. Crainic, S. van der Werf, and R. E. Streeck. 1986. A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles. Science 233:472-475.
8. Doe, B., M. Selby, S. Barnett, J. Baenziger, and C. M. Walker. 1996. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93:8578-8583.
9. Dubuisson, J., H. H. Hsu, R. C. Cheung, H. B. Greenberg, D. G. Russell, and C. M. Rice. 1994. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J. Virol. 68:6147-6160.
10. Dubuisson, J., and C. M. Rice. 1996. Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin. J. Virol. 70:778-786.
11. Farci, P., H. J. Alter, S. Govindarajan, D. C. Wong, R. Engte, R. R. Lesniewski, I. K. Mushahwar, S. M. Desai, R. H. Miller, N. Ogata, et al. 1992. Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140.
12. Ferrari, C., A. Valli, L. Galati, A. Penna, P. Scaccaglia, T. Giuberti, C. Schienchi, G. Missale, M. Garcia Marin, and F. Fiaccadori. 1994. T cell response to structural and non-structural hepatitis C virus antigen in persistent and self-limited hepatitis C virus infection. Hepatology 19:286-295.
13. Fournillier-Jacob, A., A. Cahour, N. Escriou, M. Girard, and C. Wychowski. 1996. Processing of the E1 glycoprotein of hepatitis C virus expressed in J mammalian cells. J. Gen. Virol. 77:1055-1064.
14. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
15. Fuller, D. H., and J. R. Haynes. 1994. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral responses in mice receiving a DNA-based glycoprotein. AIDS Res. Hum. Retroviruses 10 1433-1441.
16. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90: 11478-11482.
17. Grakoui, A., C. Wychowski, C. Lin, S. M. Feinstone, and C. M. Rice. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1385-1395.
18. Haynes, J. R., D. H. Fuller, M. D. Eisenbraun, M. J. Ford, and T. M. Pertmer. 1994. Accell Particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses. AIDS Res. Hum. Retroviruses 10:S43-S45.
19. Higashi, Y., S. Kakumi, K. Yoshioka, T. Wakita, M. Mizokami, K. Ohba, Y. Ito, T. M. Ishikawa, and N. Nagai. 1993. Dynamics change in the E2/NS1 region of hepatitis C virus in vivo. Virology 197:659-668.
20. Hoffman, R. M., H. M. Diepolder, R. Zachoval, F.-M. Zwiebel, M.-C. Jung, S. Scholz, H. Nitschko, G. Riethmuller, and G. R. Pape. 1995. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of infection. Hepatology 21:632-638.
21. Inchauspé, G., L. Vitviski, M. A. Major, G. Jung, U. Spengler, M. Maisonnas, and C. Trépo. 1997. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol. 16:185-195.
22. Jarvis, L. M., H. G. Watson, F. MsOmish, J. F. Peutherer, C. A. Ludlam, and P. Simmonds. 1992. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J. Infect. Dis. 170:1018-1022.
23. Kato, N., H. Sekiya, Y. Ootsuyama, T. Nakazawa, M. Hijikata, S. Ohkoshi, and K. Shimotohno. 1993. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J. Virol. 67:3923-3930.
24. Kato, N., Y. Ootsuyama, H. Sekiya, S. Ohkoshi, T. Nakazawa, M. Hijikata, and K. Shimotohno. 1994. Genetic drift in hypervariable region I of the viral genome in persistent hepatitis C virus infection. J. Virol. 68:4776-4784.
25. Kliks, S. C., T. Shioda, N. L. Haigwood, and J. Levy. 1993. V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:11518-11522.
26. Kojima. M., T. Osuga, F. Tsuda, T. Tanaka, and H. Okamoto. 1994. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees. Virology 204:665-672.
27. Koshy, R., and G. Inchauspé. 1996. Evaluation of hepatitis C virus protein epitopes for vaccine development. Trends Biotechnol. 14:365-369.
28. Lagging, L. M., K. Meyer, D. Hoft, M. Houghton, R. B. Belshe, and R. Ray. 1995. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:5859-5863.
29. Leroux-Roels, G., C. Alvadero Esquivel, R. DeLeys, L. Stuyver, A. Elewaut, J. Philippé, L. Desombre, J. Paradijs, and G. Maerteens. 1996. Lymphoproliferative responses to hepatitis C virus core, E1, E2and NS3 in patients with chronic hepatitis C infection treated with interferon alfa. Hepatology 23:8-16.
30. Lesniewski, R., G. Okasinski, R. Carrick, C. Van Sant, S. Desai, R. Johnson, J. Schleffel, B. Moore, and I. Mushahwar. 1995. Antibody to hepatitis C virus second envelope (HCV E2) glycoprotein: a new marker of HCV infection closely associated with viremia. J. Med. Virol. 45:415-422.
31. Lu, S., J. C. Santoro, D. H. Fuller, J. R. Haynes, and H. L. Robinson, 1995. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 209:147-154.
32. 31a.Maertens, G., et al. Unpublished data.
33. Major, M. E., L. Vitvitski, M. A. Mink, M. Schleef, R. G. Whalen, C. Trèpo, and G. Inchauspé. 1995. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 69:5798-5805.
34. Mast, E. E., and M. J. Alter. 1993. Epidemiology of viral hepatitis: an overview. Semi. Virol. 4:273-283.
35. Michel, M. L., P. Pontisso, E. Sobezak, Y. Malpiece, R. E. Streeck, and P. Tiollais. 1984. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc. Natl. Acad. Sci. USA 81:7708-7712.
36. Michel, M. L., M. Mancini, E. Sobczak, V. Favier, D. Guetard, E. M. Bahraoui, and P. Tiollais. 1988. Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV-hepatitis B surface antigen particles. Proc. Natl. Acad. Sci. USA 85:7957-7961.
37. Michel, M., H. L. Davis, M. Schleef, M. Mancini, P. Tiollais, and R. G. Whalen. 1995. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infections in humans. Proc. Natl. Acad. Sci. USA 92:5307-5311.
38. Mink, A. M., S. Bénichou, P. Madaule, P. Tiollais, A. M. Prince, and G. Inchauspé. 1994. Characterization and mapping of a B-cell immunogenic domain in hepatitis c virus E2 glycoprotein using a yeast peptide library. Virology 200:246-255.
39. Pertner, T. M., T. R. Roberts, and J. R. Haynes. 1996. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:6119-6125.
40. Prince, A. M., B. Brotman, T. Huima, D. Pascual, M. Jaffrey, and G. Inchauspé. 1992. Immunity in hepatitis C virus infection. J. Infect. Dis. 165:438-443.
41. Rosa. D., S. Campagnoli, C. Moretto, E. Cuenzi, L. Cousens, M. Chin, C. Dong, A. J. Weiner, J. Y. N. Lau, Q.-L. Choo, D. Chien, P. Pileri, M. Houghton, and S. Abrignani. 1996. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. USA 93:1759-1763.
42. Saito, I., T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kituchi, S. Koi, M. Onji, Y. Ohta, Q.-L. Choo, M. Houghton, and G. Kuo. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87:6547-6549.
43. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, N.Y.
44. Sarraco, G., M. L. Abate, M. Baldi, P. L. Calvo, P. Manzini, M. R. Brunetto, F. Oliveri, G. Kuo, D. Chien, M. Houghton, G. Verme, M. Rizetto, and F. Bonino. 1994. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis. Liver 14:65-70.
45. Sekiya, H., N. Kato, Y. Ootsuyama, T. Nakazawa, K. Yamauchi, and K. Shimotohno. 1994. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1. Int. J. Cancer 57:664-670.
46. Tokushige, K., T. Wakita, C. Pachuk, D. Moradpour, D. B. Weiner, V. R. Zurawski, and J. Wands. 1996. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 24:14-20.
47. van Doom, L. J., I. Capriles, G. Maertens, R. DeLeys, K. Murray, T. Kos, H. Schellekens, and W. Quint. 1995. Sequence evolution of the hypervariable region in the putative envelope region E2/NSI of hepatitis C virus is correlated with specific humoral immune responses. J. Virol. 69:773-778.
48. Wagener, S., S. Norley, J. Z. Megede, R. Kurth, and K. Cichutek. 1996. Induction of antibodies against SIV antigens after intramuscular nucleic acid inoculation using complex expression constructs. J. Biotechnol. 44:59-65.
49. Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. I. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156-4160.
50. Weiner, A. J., M. J. Brauer, J. Rosemblatt, K. H. Richman, J. Tung, K. Crawford, F. Bonino, G. Saracco, Q.-L. Choo, M. Houghton, and J. H. Han. 1991. Variable and hypervariable domains are found in the regions of HCV corresponding to flavivirus envelope and NS1 proteins and the pestivirus envelope proteins. Virology 180:842-848.
51. Weiner, A. J., H. M. Geysens, C. Christopherson, E. J. Hall, T. J. Mason, G. Saracco, F. Bonino, K. Crawford, C. D. Marion, K. A. Crawford, M. Brunetto, P. J. Barr, T. Miyamura, J. McHutchinson, and M. Houghton. 1992. Evidence of immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA 89:3468-3472.
52. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
53. Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng, and H. C. Ertl. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199: 132-140.
54. Zibert, A., E. Schreier, and M. Roggendorf. 1995. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208:653-661.